Dora Mugoli Chigoho

Dora Chigoho studied Pharmaceutical sciences at Universiteit Antwerpen where she obtained a Master of Drug Development and graduated as a pharmacist. Dora did her Master's thesis at the In Vivo Cellular and Molecular Imaging (ICMI) laboratory under the supervision of PhD student Jessica Bridoux and Prof. Dr. Catarina Xavier. During her Master's thesis, she acquired knowledge and experience on galium-68-immunolabeling using nanobodies targeting human-PD-L1 receptors. Dora started her PhD in October 2020 at the ICMI laboratory focusing on unraveling the renal pathway of radiolabeled nanobodies under the supervision of Prof. Dr. Sophie Hernot.